Chrysea Acquires Rodon Biologics to Strengthen Capabilities in Synthetic Biology and Biopharmaceuticals Development
Chrysea Acquires Rodon Biologics to Strengthen Capabilities in Synthetic Biology and Biopharmaceutical Products Development. 13 February 2024 Chrysea acquires operational capability, skills and know-how, to drive capital-efficiency. Chrysea accesses a...